Study shows safety and efficacy of Curodont Repair

Curodont Repairshows tremendous potential in the treatment of early dental caries. Applied to an early caries lesion, Curodont Repairforms a scaffold within the lesion to allow new hydroxyapatite (tooth mineral) crystals to form and grow. Ideally, the lesion will mineralise within several weeks.

 On August 23, 2013 the paper “Treatment of early caries lesions using biomimetic self-assembling peptides – a clinical safety trial” describing research led by Professors Paul Brunton and Jennifer Kirkham and Dr Amalia Aggeli from the University of Leeds was published in the British Dental Journal, part of the renowned Nature Publishing Group.

The study shows the safety and efficacy of the early caries therapy with P11-4 – the main component of CurodontRepair.

The study is an integral part of the clinical program evaluating the efficacy of Curodont Repair and has indicated that biomimetic mineralisation is an effective tool in the treatment of early tooth decay.

„The Self-Assembling Peptide Technology investigated has the potential for widespread applications in dentistry offering novel therapeutic treatments that will be of great benefit to patients” says Prof. Paul Brunton, principle clinical investigator of the study.

About credentis ag
credentis ag, founded in 2010, is headquartered in the Technopark, Aargau, Switzerland. credentis has won multiple awards as well as support from organizations such as Genilem. Public grants include Swiss National Fund, Aargauer Forschungsfond and the Medical Technologies IKC together with the University of Leeds.